Fig. 6From: Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel diseaseIn vivo biocompatibility evaluation. A H&E staining, B blood routine index tests, and C blood biochemistry. T-tests were performed for statistical comparison, *p < 0.05, **p < 0.01, ***p < 0.001Back to article page